FOMX Foamix Pharmaceuticals Ltd.

+0.04  (+1%)
Previous Close 3.79
Open 3.78
Price To Book 2.25
Market Cap 208074820
Shares 54,365,955
Volume 260,853
Short Ratio
Av. Daily Volume 393,917

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data released November 7, 2018. Primary endpoints met. Safety data reported February 27, 2019.
Papulopustular rosacea
PDUFA date October 20, 2019.
Phase 2 data released December 2015
Acne-like rash in cancer patients
Update to be provided as it materializes.

Latest News

  1. Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2019
  2. Edited Transcript of FOMX earnings conference call or presentation 1-Mar-19 1:30pm GMT
  3. Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
  4. Foamix Pharmaceuticals to Present at the Cowen & Company 39th Annual Health Care Conference
  5. Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update
  6. How Many Insiders Bought Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) Shares?
  7. Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to One Year
  8. Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting
  9. Will Foamix (FOMX) Report Negative Earnings Next Week? What You Should Know
  10. Foamix Pharmaceuticals Fourth Quarter Financial Results Conference Call & Webcast Scheduled for March 1
  11. Foamix Announces Appointment of Sharon Barbari to Board of Directors
  12. Are Foamix Pharmaceuticals Ltd.’s (NASDAQ:FOMX) Interest Costs Too High?
  13. Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne
  14. Is Foamix Pharmaceuticals Ltd (FOMX) A Good Stock To Buy?
  15. Could Foamix Pharmaceuticals Ltd.’s (NASDAQ:FOMX) Investor Composition Influence The Stock Price?
  16. Edited Transcript of FOMX earnings conference call or presentation 9-May-18 12:30pm GMT
  17. Foamix Announces Appointment of Matt Wiley as Chief Commercial Officer
  18. The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings
  19. Foamix Announces Appointment of Anthony Bruno to Board of Directors
  20. Edited Transcript of FOMX earnings conference call or presentation 8-Nov-18 1:30pm GMT